Low-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis May 27, 2020checkorphan Learn more about: Relapsing Polychondritis Related Clinical Trial Longitudinal Study for Relapsing Polychondritis Tocilizumab for Relapsing Polychondritis Study on the Safety of Abatacept in Relapsing Polychondritis Single Patient Study to Treat Relapsing Polychondritis With Tocilizumab Low-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis Recruitment InformationAdministrative Informations